Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-CO2 pseudogene 34 is classified as a pseudogene in the human genome, meaning it is a DNA sequence similar to the functional mitochondrial gene MT-CO2 but does not encode a functional protein product due to accumulated mutations or incomplete gene structure[2][4]. Unlike MT-CO2, which is crucial for mitochondrial electron transport and implicated in mitochondrial disease when mutated[1][3][7], MTCO2P34 has no known biological function, disease relevance, or therapeutic applications. It is listed as a pseudogene in major genomic databases (HGNC:52316, NCBI Gene:109729142, Ensembl:ENSG00000232198), and current biomedical literature does not support any role for MTCO2P34 in drug response, disease, or molecular pathways[2][4]. If you require information on the functional mitochondrial gene MT-CO2 (cytochrome c oxidase subunit II), it is a well-characterized enzyme subunit in respiratory complex IV[1][3][7]. However, MTCO2P34 refers solely to the non-functional pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-CO2 pseudogene 34 (MTCO2P34).